Literature DB >> 15761117

Mutation of the DRY motif reveals different structural requirements for the CC chemokine receptor 5-mediated signaling and receptor endocytosis.

Bernard Lagane1, Sébastien Ballet, Thierry Planchenault, Karl Balabanian, Emmanuel Le Poul, Cédric Blanpain, Yann Percherancier, Isabelle Staropoli, Gilbert Vassart, Martin Oppermann, Marc Parmentier, Françoise Bachelerie.   

Abstract

CC chemokine receptor 5 (CCR5) is a G protein-coupled receptor that governs migration of leukocytes and serves as a coreceptor for the R5 tropic strains of human immunodeficiency virus (HIV). CCR5-mediated signaling in response to CC chemokines relies on G protein activation. Desensitization, which rapidly turns off G protein-dependent signaling, involves phosphorylation of CCR5 that promotes interaction of the receptor with beta-arrestins for endocytosis. Whether coupling to G proteins, desensitization, and endocytosis of CCR5 require the same structural determinants remains a matter of investigation. Here, we show that CCR5 displayed agonist-independent coupling to G proteins. This constitutive activity of the receptor was abrogated by TAK779 (N,N-dimethyl-N-[4-[[[2-(4-methylphenyl)-6,7-dihydro-5H-benzocyclohepten-8-yl]carbonyl]amino]benzyl]tetrahydro-2H-pyran-4-aminium chloride), a nonpeptidic CCR5 ligand that inhibits HIV infection and was found to depend on the integrity of the Asp-Arg-Tyr (DRY) motif. Changing Arg-126 by the neutral residue Asn (R126N-CCR5 mutant) abolished CCR5-mediated activation of G proteins, either constitutively or in response to agonists. In contrast, R126N-CCR5 not only retained agonist-promoted phosphorylation and beta-arrestin-dependent endocytosis but also displayed a higher basal phosphorylation than wild-type CCR5. Expression of beta-arrestin in R126N-CCR5-expressing cells resulted in receptor down-regulation, thereby suggesting that R126N-CCR5 spontaneously interacts with beta-arrestins. However, although expression of beta-arrestin favored wild-type CCR5-mediated chemotaxis, it failed to promote migration of cells expressing R126N-CCR5. Overall, these data indicate that structural requirements for CCR5-mediated activation of G proteins, albeit not involved in receptor desensitization and internalization, are needed for beta-arrestin-mediated chemotaxis. These results have implications for how distinct biological responses of CCR5 might rely on a different set of receptor conformations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15761117     DOI: 10.1124/mol.104.009779

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  35 in total

Review 1.  Beyond desensitization: physiological relevance of arrestin-dependent signaling.

Authors:  Louis M Luttrell; Diane Gesty-Palmer
Journal:  Pharmacol Rev       Date:  2010-04-28       Impact factor: 25.468

2.  Selectivity in the Use of Gi/o Proteins Is Determined by the DRF Motif in CXCR6 and Is Cell-Type Specific.

Authors:  Satya P Singh; John F Foley; Hongwei H Zhang; Darrell E Hurt; Jennifer L Richards; Craig S Smith; Fang Liao; Joshua M Farber
Journal:  Mol Pharmacol       Date:  2015-08-27       Impact factor: 4.436

3.  Conserved changes in envelope function during human immunodeficiency virus type 1 coreceptor switching.

Authors:  Cristina Pastore; Rebecca Nedellec; Alejandra Ramos; Oliver Hartley; John L Miamidian; Jacqueline D Reeves; Donald E Mosier
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

4.  Paracrine transactivation of the CB1 cannabinoid receptor by AT1 angiotensin and other Gq/11 protein-coupled receptors.

Authors:  Gábor Turu; Péter Várnai; Pál Gyombolai; László Szidonya; László Offertaler; György Bagdy; George Kunos; László Hunyady
Journal:  J Biol Chem       Date:  2009-04-07       Impact factor: 5.157

5.  HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines.

Authors:  Philippe Colin; Yann Bénureau; Isabelle Staropoli; Yongjin Wang; Nuria Gonzalez; Jose Alcami; Oliver Hartley; Anne Brelot; Fernando Arenzana-Seisdedos; Bernard Lagane
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-21       Impact factor: 11.205

6.  Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entry.

Authors:  Jun Jin; Philippe Colin; Isabelle Staropoli; Evelyne Lima-Fernandes; Cécile Ferret; Arzu Demir; Sophie Rogée; Oliver Hartley; Clotilde Randriamampita; Mark G H Scott; Stefano Marullo; Nathalie Sauvonnet; Fernando Arenzana-Seisdedos; Bernard Lagane; Anne Brelot
Journal:  J Biol Chem       Date:  2014-05-22       Impact factor: 5.157

7.  Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the protean effects of "selective" antagonists.

Authors:  Denis Sohy; Hideaki Yano; Patricia de Nadai; Eneko Urizar; Aude Guillabert; Jonathan A Javitch; Marc Parmentier; Jean-Yves Springael
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

8.  Double-edged genetic swords and immunity: lesson from CCR5 and beyond.

Authors:  Sunil K Ahuja; Weijing He
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

9.  Functional anatomy of the full-length CXCR4-CXCL12 complex systematically dissected by quantitative model-guided mutagenesis.

Authors:  Bryan S Stephens; Tony Ngo; Irina Kufareva; Tracy M Handel
Journal:  Sci Signal       Date:  2020-07-14       Impact factor: 8.192

10.  Activation of intracellular signaling pathways by the murine cytomegalovirus G protein-coupled receptor M33 occurs via PLC-{beta}/PKC-dependent and -independent mechanisms.

Authors:  Joseph D Sherrill; Melissa P Stropes; Olivia D Schneider; Diana E Koch; Fabiola M Bittencourt; Jeanette L C Miller; William E Miller
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.